Recent research has demonstrated that treatment with naringenin after the onset of collagen-induced arthritis can alleviate arthritis symptoms by modulating the levels of the cytokines IFN-γ and IL-17, myeloperoxidase, nitric oxide, and C-reactive protein (Hajizadeh et al., 2021). The gene discussed is IL17A; the disease is arthritic joint disease.